mRECIST for systemic therapies: More evidence is required before recommendations can be made

Affiliations

• ¹ Medical Oncology, Centre Eugène Marquis, Rennes, France. Electronic address: [email protected].
• ² Department of Molecular and Clinical Cancer Medicine, University of Liverpool, and The Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom.
• ³ CHU Hôpital Saint André, Bordeaux, France.
• ⁴ Medical Oncology, Centre Eugène Marquis, Rennes, France.
• ⁵ Groupement Hospitalier Lyon Nord, Hepatology Unit, Lyon, France.
• ⁶ Royal Free Hospital, London, United Kingdom; UCL Cancer Institute, University College London, London, United Kingdom.